Sun Pharmaceutical Industries Share Price Today - Live Blog for March 25, 2025

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.16%, reaching the current market price of ₹1,766.00. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.10%, and as of now, it's trading at ₹1,766.00 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.14%, a situation worth noting. At present, the stock is trading at ₹1,760.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 37.4700, while the industry PE ratio is 34.5704.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.34% drop, and it's now trading at ₹1,762.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd observed a -0.22% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,763.20. The stock has a PE ratio of 37.4700, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

With a -0.22% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,763.20. Investors should examine the factors driving this decline. The stock's PE ratio is 37.4700, whereas the industry PE ratio stands at 34.5704.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.19%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,766.90 per share.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.19% uptick, and they are currently valued at ₹1,766.90, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

With a -0.01% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,766.30. The stock is currently trading at a PE of 37.4700, while the industry PE is 34.5704, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd experienced a -0.01% dip in its share price and is currently trading at ₹1,766.30. The stock has a PE ratio of 37.4700, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.01% slump and is currently trading at ₹1,766.30. While the stock maintains a PE ratio of 37.4700, the industry PE is 34.5704, raising questions about valuation.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.03%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,765.10 per share.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.03%, and it is currently trading at ₹1,765.10. Additionally, the stock maintains a PE ratio of 37.4700, while the industry PE is 34.5704.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.17% upswing and is currently trading at ₹1,764.65, indicating strong market sentiment.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.07% decline, and it currently trades at ₹1,761.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.06% increase and currently trading at ₹1,764.35 per share. This upward trajectory is turning heads in the market.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.18% drop, and it's now trading at ₹1,763.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.07% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,767.85 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.18%, with the current market value at ₹1,766.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.15% surge in its share price and is presently trading at ₹1,769.35, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd shares saw a -0.01% decrease, reaching a current market price of ₹1,768.20. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.4700, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.07%, a situation worth noting. At present, the stock is trading at ₹1,768.50. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 37.4700, while the industry PE ratio is 34.5704.

With a -0.30% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,769.75. This development raises questions about the factors behind the decline. The stock's PE ratio is 37.4700, while the industry PE is 34.5704.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.11%, reaching the current market price of ₹1,776.00. This surge is indicative of the stock's recent positive performance.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.18%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,774.65, but investors are assessing whether this is a temporary dip or a long-term trend.

With a -0.47% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,776.35. Investors should examine the factors driving this decline. The stock's PE ratio is 37.4700, whereas the industry PE ratio stands at 34.5704.

With a -0.38% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,786.00. Investors should examine the factors driving this decline. The stock's PE ratio is 37.4700, whereas the industry PE ratio stands at 34.5704.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.28% increase and currently trading at ₹1,792.95 per share. This upward trajectory is turning heads in the market.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.49%, and as of now, it's trading at ₹1,788.75 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.33%, and it is currently trading at ₹1,780.15. Additionally, the stock maintains a PE ratio of 37.4700, while the industry PE is 34.5704.

After a -1.04% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,776.30. The stock has a PE ratio of 37.4700, an ROE of 15.9938% and a debt to equity ratio of 0.0372.